Associate toxin-antitoxin with CRISPR-Cas to kill multidrug-resistant pathogens

Abstract CreTA, CRISPR-regulated toxin-antitoxin (TA), safeguards CRISPR-Cas immune systems by inducing cell dormancy/death upon their inactivation. Here, we characterize a bacterial CreTA associating with the I-F CRISPR-Cas in Acinetobacter. CreT is a distinct bactericidal small RNA likely targetin...

Full description

Bibliographic Details
Main Authors: Rui Wang, Xian Shu, Huiwei Zhao, Qiong Xue, Chao Liu, Aici Wu, Feiyue Cheng, Lingyun Wang, Yihan Zhang, Jie Feng, Nannan Wu, Ming Li
Format: Article
Language:English
Published: Nature Portfolio 2023-04-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-023-37789-y
_version_ 1797845890537357312
author Rui Wang
Xian Shu
Huiwei Zhao
Qiong Xue
Chao Liu
Aici Wu
Feiyue Cheng
Lingyun Wang
Yihan Zhang
Jie Feng
Nannan Wu
Ming Li
author_facet Rui Wang
Xian Shu
Huiwei Zhao
Qiong Xue
Chao Liu
Aici Wu
Feiyue Cheng
Lingyun Wang
Yihan Zhang
Jie Feng
Nannan Wu
Ming Li
author_sort Rui Wang
collection DOAJ
description Abstract CreTA, CRISPR-regulated toxin-antitoxin (TA), safeguards CRISPR-Cas immune systems by inducing cell dormancy/death upon their inactivation. Here, we characterize a bacterial CreTA associating with the I-F CRISPR-Cas in Acinetobacter. CreT is a distinct bactericidal small RNA likely targeting several essential RNA molecules that are required to initiate protein synthesis. CreA guides the CRISPR effector to transcriptionally repress CreT. We further demonstrate a proof-of-concept antimicrobial strategy named ATTACK, which AssociaTes TA and CRISPR-Cas to Kill multidrug resistant (MDR) pathogens. In this design, CRISPR-Cas is programed to target antibiotic resistance gene(s) to selectively kill MDR pathogens or cure their resistance, and when CRISPR-Cas is inactivated or suppressed by unwanted genetic or non-genetic events/factors, CreTA triggers cell death as the last resort. Our data highlight the diversity of RNA toxins coevolving with CRISPR-Cas, and illuminate a combined strategy of CRISPR and TA antimicrobials to ‘ATTACK’ MDR pathogens.
first_indexed 2024-04-09T17:46:17Z
format Article
id doaj.art-9af6f50038e3452486b995a0d6ccf7c5
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-04-09T17:46:17Z
publishDate 2023-04-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-9af6f50038e3452486b995a0d6ccf7c52023-04-16T11:18:52ZengNature PortfolioNature Communications2041-17232023-04-0114111310.1038/s41467-023-37789-yAssociate toxin-antitoxin with CRISPR-Cas to kill multidrug-resistant pathogensRui Wang0Xian Shu1Huiwei Zhao2Qiong Xue3Chao Liu4Aici Wu5Feiyue Cheng6Lingyun Wang7Yihan Zhang8Jie Feng9Nannan Wu10Ming Li11CAS Key Laboratory of Microbial Physiological and Metabolic Engineering, State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of SciencesCAS Key Laboratory of Microbial Physiological and Metabolic Engineering, State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of SciencesCAS Key Laboratory of Microbial Physiological and Metabolic Engineering, State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of SciencesCAS Key Laboratory of Microbial Physiological and Metabolic Engineering, State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of SciencesCAS Key Laboratory of Microbial Physiological and Metabolic Engineering, State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of SciencesCAS Key Laboratory of Microbial Physiological and Metabolic Engineering, State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of SciencesCAS Key Laboratory of Microbial Physiological and Metabolic Engineering, State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of SciencesCAS Key Laboratory of Microbial Physiological and Metabolic Engineering, State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of SciencesCAS Key Laboratory of Microbial Physiological and Metabolic Engineering, State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of SciencesCollege of Life Science, University of Chinese Academy of SciencesShanghai Institute of Phage, Shanghai Public Health Clinical Center, Fudan UniversityCAS Key Laboratory of Microbial Physiological and Metabolic Engineering, State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of SciencesAbstract CreTA, CRISPR-regulated toxin-antitoxin (TA), safeguards CRISPR-Cas immune systems by inducing cell dormancy/death upon their inactivation. Here, we characterize a bacterial CreTA associating with the I-F CRISPR-Cas in Acinetobacter. CreT is a distinct bactericidal small RNA likely targeting several essential RNA molecules that are required to initiate protein synthesis. CreA guides the CRISPR effector to transcriptionally repress CreT. We further demonstrate a proof-of-concept antimicrobial strategy named ATTACK, which AssociaTes TA and CRISPR-Cas to Kill multidrug resistant (MDR) pathogens. In this design, CRISPR-Cas is programed to target antibiotic resistance gene(s) to selectively kill MDR pathogens or cure their resistance, and when CRISPR-Cas is inactivated or suppressed by unwanted genetic or non-genetic events/factors, CreTA triggers cell death as the last resort. Our data highlight the diversity of RNA toxins coevolving with CRISPR-Cas, and illuminate a combined strategy of CRISPR and TA antimicrobials to ‘ATTACK’ MDR pathogens.https://doi.org/10.1038/s41467-023-37789-y
spellingShingle Rui Wang
Xian Shu
Huiwei Zhao
Qiong Xue
Chao Liu
Aici Wu
Feiyue Cheng
Lingyun Wang
Yihan Zhang
Jie Feng
Nannan Wu
Ming Li
Associate toxin-antitoxin with CRISPR-Cas to kill multidrug-resistant pathogens
Nature Communications
title Associate toxin-antitoxin with CRISPR-Cas to kill multidrug-resistant pathogens
title_full Associate toxin-antitoxin with CRISPR-Cas to kill multidrug-resistant pathogens
title_fullStr Associate toxin-antitoxin with CRISPR-Cas to kill multidrug-resistant pathogens
title_full_unstemmed Associate toxin-antitoxin with CRISPR-Cas to kill multidrug-resistant pathogens
title_short Associate toxin-antitoxin with CRISPR-Cas to kill multidrug-resistant pathogens
title_sort associate toxin antitoxin with crispr cas to kill multidrug resistant pathogens
url https://doi.org/10.1038/s41467-023-37789-y
work_keys_str_mv AT ruiwang associatetoxinantitoxinwithcrisprcastokillmultidrugresistantpathogens
AT xianshu associatetoxinantitoxinwithcrisprcastokillmultidrugresistantpathogens
AT huiweizhao associatetoxinantitoxinwithcrisprcastokillmultidrugresistantpathogens
AT qiongxue associatetoxinantitoxinwithcrisprcastokillmultidrugresistantpathogens
AT chaoliu associatetoxinantitoxinwithcrisprcastokillmultidrugresistantpathogens
AT aiciwu associatetoxinantitoxinwithcrisprcastokillmultidrugresistantpathogens
AT feiyuecheng associatetoxinantitoxinwithcrisprcastokillmultidrugresistantpathogens
AT lingyunwang associatetoxinantitoxinwithcrisprcastokillmultidrugresistantpathogens
AT yihanzhang associatetoxinantitoxinwithcrisprcastokillmultidrugresistantpathogens
AT jiefeng associatetoxinantitoxinwithcrisprcastokillmultidrugresistantpathogens
AT nannanwu associatetoxinantitoxinwithcrisprcastokillmultidrugresistantpathogens
AT mingli associatetoxinantitoxinwithcrisprcastokillmultidrugresistantpathogens